OPL Share Price Performance
AU$0.021
-0.00 (-8.70%)
Price AU$0.021
Share PriceAU$0.021
OPL Community Narratives
There are no narratives available yet.
Recent OPL News & Updates
No updates
Opyl Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.011
- Gross Margin
- -651.59%
- Net Profit Margin
- -1,293.90%
- Debt/Equity Ratio
- -137.8%
Opyl Limited Competitors
About OPL
- Founded
- 1994
- Employees
- n/a
- CEO
- WebsiteView website
Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.
Australian Market Performance
- 7 Days: 1.1%
- 3 Months: 8.3%
- 1 Year: 14.7%
- Year to Date: 7.4%
The market is up 1.1% over the last week, with the Financials sector leading the way, up 1.1%. As for the past 12 months, the market is up 15%. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading